ClinicalTrials.gg
Sign In

Lichen Sclerosus et Atrophicus clinical trials

The registry lists 30 studies for Lichen Sclerosus et Atrophicus across more than 10 countries. 8 are recruiting or about to start. 20 of them are mainly about Lichen Sclerosus et Atrophicus (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-13.

Get an email when these change. Save the Lichen Sclerosus et Atrophicus studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
13
Recruiting
5
Status unknown
5
Not yet recruiting
2
Terminated
2
Enrolling by invitation
1

Phase

Phase 2
4
Phase 3
3

Where

United States
11
Canada
4
Switzerland
4
Sweden
2
United Kingdom
2
Croatia
1

Who runs them

Center for Vulvovaginal Disorders (5) · Northwestern University (2) · University of Zurich (1) · Stratpharma AG (1) · Ruhr University of Bochum (1) · Region Västerbotten (1) · Medical University of Graz (1) · 1st Federal Budgetary Healthcare Institution Volga District Medical Center (1)

What is being tested here

Drugs under test in Lichen Sclerosus et Atrophicus studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nemolizumab101
Delgocitinib111
Clobetasol012
Platelet rich plasma002
Ruxolitinib001
Pimecrolimus001

Coming up

1phase 3 study under way
5studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 5

Who these studies take

Of the 5 Lichen Sclerosus et Atrophicus studies recruiting now, 5 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 1 (20%) take children under 18. 2 (40%) are for women only and 1 (20%) for men only; 3 (60%) take healthy volunteers.

Recruiting studies that take each age, of 5
AgeWomenMen
101 (20%)1 (20%)
184 (80%)3 (60%)
304 (80%)3 (60%)
404 (80%)3 (60%)
504 (80%)3 (60%)
654 (80%)3 (60%)
754 (80%)3 (60%)
854 (80%)3 (60%)

Across all 30 studies, recruiting or not: 7% stop at 75 or younger and 0% at 65; 13% take children; 83% are for women only and 3% for men only; 33% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 30 of 30. search them.